Trial of Buprenorphine/Naloxone for Opiate Dependence - 2

National Institutes of Health (NIH)

Status and phase: Completed; Phase 2

Conditions: Opioid-Related Disorders; Substance-Related Disorders

Treatments: Drug: Buprenorphine/naloxone

Study type: Interventional

Funder types: Other; NIH

Identifiers

NCT00000353

Y01-3-0012-2

NIDA-3-0012-2

Details and patient eligibility

About

The purpose of this study is to determine the efficacy and safety of a buprenorphine/naloxone sublingual tablet formulation as an office-based therapy for opiate dependence treatment.

Sex: All

Ages: 19 to 57 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Please contact site for information.